APA (7th ed.) Citation

Saylor, P. J., Mahmood, U., Kunawudhi, A., Smith, M. R., Palmer, E. L., & Michaelson, M. D. (2012). Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: Analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancer. The Journal of nuclear medicine (1978), 53(11), 1670-1675. https://doi.org/10.2967/jnumed.112.105007

Chicago Style (17th ed.) Citation

Saylor, Philip J., Umar Mahmood, Anchisa Kunawudhi, Matthew R. Smith, Edwin L. Palmer, and M Dror Michaelson. "Multitargeted Tyrosine Kinase Inhibition Produces Discordant Changes Between 99mTc-MDP Bone Scans and Other Disease Biomarkers: Analysis of a Phase II Study of Sunitinib for Metastatic Castration-resistant Prostate Cancer." The Journal of Nuclear Medicine (1978) 53, no. 11 (2012): 1670-1675. https://doi.org/10.2967/jnumed.112.105007.

MLA (9th ed.) Citation

Saylor, Philip J., et al. "Multitargeted Tyrosine Kinase Inhibition Produces Discordant Changes Between 99mTc-MDP Bone Scans and Other Disease Biomarkers: Analysis of a Phase II Study of Sunitinib for Metastatic Castration-resistant Prostate Cancer." The Journal of Nuclear Medicine (1978), vol. 53, no. 11, 2012, pp. 1670-1675, https://doi.org/10.2967/jnumed.112.105007.